0001209191-23-059363.txt : 20231220 0001209191-23-059363.hdr.sgml : 20231220 20231220165400 ACCESSION NUMBER: 0001209191-23-059363 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231218 FILED AS OF DATE: 20231220 DATE AS OF CHANGE: 20231220 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Miller Deborah Ann CENTRAL INDEX KEY: 0001868741 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40671 FILM NUMBER: 231501945 MAIL ADDRESS: STREET 1: C/O NUVALENT, INC. STREET 2: ONE BROADWAY, 14TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02142 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Nuvalent, Inc. CENTRAL INDEX KEY: 0001861560 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE BROADWAY, 14TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 508-446-2272 MAIL ADDRESS: STREET 1: ONE BROADWAY, 14TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02142 4 1 doc4.xml FORM 4 SUBMISSION X0508 4 2023-12-18 0 0001861560 Nuvalent, Inc. NUVL 0001868741 Miller Deborah Ann C/O NUVALENT, INC. ONE BROADWAY, 14TH FLOOR CAMBRIDGE MA 02142 0 1 0 0 Chief Legal Officer 0 Class A Common Stock 2023-12-18 4 M 0 33046 27.85 A 33046 D Class A Common Stock 2023-12-18 4 S 0 33046 75.82 D 0 D Class A Common Stock 2023-12-19 4 M 0 5000 18.93 A 5000 D Class A Common Stock 2023-12-19 4 S 0 5000 75.00 D 0 D Stock Option (Right to Buy) 27.85 2023-12-18 4 M 0 33046 0.00 D 2033-01-06 Class A Common Stock 33046 111154 D Stock Option (Right to Buy) 18.93 2023-12-19 4 M 0 5000 0.00 D 2032-01-04 Class A Common Stock 5000 102000 D The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $75.40 to $76.36, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, Nuvalent, Inc. or any security holder of Nuvalent, Inc., upon request, full information regarding the number of shares sold at each separate price. The shares underlying this option have vested or shall vest over the next four years following January 6, 2023 in equal monthly installments, subject to continued service to Nuvalent, Inc. through the applicable vesting date. The shares underlying this option vest as follows: 25% of the shares vested on January 4, 2023, and the remainder have vested or shall vest over the next three years thereafter in equal monthly installments, subject to continued service to Nuvalent, Inc. through the applicable vesting date. /s/ Deborah A. Miller 2023-12-20